Related references
Note: Only part of the references are listed.Association of plasma and urine metals levels with kidney function: A population-based cross-sectional study in China
Fei Yang et al.
CHEMOSPHERE (2019)
Vascular Cognitive Impairment and Dementia
Costantino Iadecola et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Associations between arsenic in drinking water and occurrence of end-stage renal disease with modifications by comorbidities: A nationwide population-based study in Taiwan
Ya-Yun Cheng et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2018)
Calcineurin Inhibition and Protein Kinase A Activation Limits Cognitive Dysfunction and Histopathological Damage in a Model of Dementia of the Alzheimer's Type
Amit Kumar et al.
CURRENT NEUROVASCULAR RESEARCH (2018)
Calcineurin inhibitors improve memory loss and neuropathological changes in mouse model of dementia
Amit Kumar et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
Arsenite Induces Vascular Endothelial Cell Dysfunction by Activating IRE1α/XBP1s/HIF1α-Dependent ANGII Signaling
Xiuduan Xu et al.
TOXICOLOGICAL SCIENCES (2017)
Pharmacological activation of protein kinase A improves memory loss and neuropathological changes in a mouse model of dementia of Alzheimer's type
Amit Kumar et al.
BEHAVIOURAL PHARMACOLOGY (2017)
Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type
Amit Kumar et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Emerging oral drugs for psoriasis
Tahmina Mahmood et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
Statins, cognition, and dementia-systematic review and methodological commentary
Melinda C. Power et al.
NATURE REVIEWS NEUROLOGY (2015)
PDE and cognitive processing: Beyond the memory domain
P. R. A. Heckman et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2015)
Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitors
E. Bollen et al.
NEUROPHARMACOLOGY (2015)
Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia
Ashwani Kumar et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic-pituitary-adrenal axis, cAMP signaling aspects and antioxidant defense system
Ankur Jindal et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Constitutively Active Signaling by the G Protein βγ-Subunit Mediates Intrinsically Increased Phosphodiesterase-4 Activity in Human Asthmatic Airway Smooth Muscle Cells
Aihua Hu et al.
PLOS ONE (2015)
Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease
Mark E. Gurney et al.
NEUROTHERAPEUTICS (2015)
Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats
Kinga Gawel et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
cAMP with other signaling cues converges on Rac1 to stabilize the endothelial barrier- a signaling pathway compromised in inflammation
Nicolas Schlegel et al.
CELL AND TISSUE RESEARCH (2014)
Effects of Selective Phosphodiesterases-4 Inhibitors on Learning and Memory: A Review of Recent Research
Sheng Peng et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Role of Phosphodiesterase 4-Mediated Cyclic AMP Signaling in Pharmacotherapy for Substance Dependence
Rui-Ting Wen et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases
Ana Martinez et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis
Natacha Levi Marpillat et al.
JOURNAL OF HYPERTENSION (2013)
Arsenic toxicity induced endothelial dysfunction and dementia: Pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors
Bhupesh Sharma et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Correlations Between Cholinesterase Activity and Cognitive Scores in Post-Ischemic Rats and Patients with Vascular Dementia
Yan Xiao et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Vascular dementia: Different forms of vessel disorders contribute to the development of dementia in the elderly brain
Dietmar Rudolf Thal et al.
EXPERIMENTAL GERONTOLOGY (2012)
Blood pressure, smoking and alcohol use, association with vascular dementia
Ruth Peters
EXPERIMENTAL GERONTOLOGY (2012)
Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
Petra Dunkel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Phosphodiesterase inhibitors in inflammatory bowel disease
Pooneh Salari et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Effects of Altered Cerebral Hemodynamics on Cognitive Function
Randolph S. Marshall
JOURNAL OF ALZHEIMERS DISEASE (2012)
Multi-stage segmentation of white matter hyperintensity, cortical and lacunar infarcts
Yanbo Wang et al.
NEUROIMAGE (2012)
The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury
Sandra Marie Schaal et al.
PLOS ONE (2012)
Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats
Vivek Sharma et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
[6]-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice
Debrup Chakraborty et al.
TOXICOLOGY LETTERS (2012)
A Prospective Study of Arsenic Exposure From Drinking Water and Incidence of Skin Lesions in Bangladesh
Maria Argos et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Chronic arsenic toxicity: Studies in West Bengal, India
Debendranath Guha Mazumder et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2011)
Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B-/-) mice
Kris Rutten et al.
NEUROPHARMACOLOGY (2011)
Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats
Rajesh S. Yadav et al.
NEUROTOXICOLOGY (2011)
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Sharron H. Francis et al.
PHYSIOLOGICAL REVIEWS (2011)
Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats
Bhupesh Sharma et al.
PSYCHOPHARMACOLOGY (2011)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick et al.
STROKE (2011)
The Arsenic Exposure Hypothesis for Alzheimer Disease
Gordon Gong et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Effect of Rosiglitazone in Sodium Arsenite-induced Experimental Vascular Endothelial Dysfunction
Tajpreet Kaur et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
Pitavastatin and 4′-Hydroxy-3′-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Bhupesh Sharma et al.
CURRENT NEUROVASCULAR RESEARCH (2010)
Attenuated α-adrenoceptor-mediated arterial and venous constrictions in rat models of diabetes
Joanne Y. T. Leung et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Urinary Arsenic Species and CKD in a Taiwanese Population: A Case-Control Study
Yu-Mei Hsueh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
Daniele Versari et al.
DIABETES CARE (2009)
Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs
Fatma M. El-Demerdash et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
Pathophysiology of vascular dementia
Francesco Iemolo et al.
Immunity & Ageing (2009)
PDE4 inhibitors: current status
D. Spina
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil
Bhupesh Sharma et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia
Bhupesh Sharma et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Potential target sites to modulate vascular endothelial dysfunction: Current perspectives and future directions
Pitchai Balakumar et al.
TOXICOLOGY (2008)
Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats
Rajeshkumar U Koladiya et al.
BMC Pharmacology & Toxicology (2008)
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
K. Rutten et al.
PSYCHOPHARMACOLOGY (2008)
Huperzine a for Alzheimer's disease
J. Li et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Reversal of memory deficits by atorvastatin and simvastatin in rats
Milind Parle et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2007)
Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism
Ayako Hashimoto et al.
ATHEROSCLEROSIS (2006)
Epac proteins: multi-purpose cAMP targets
Johannes L. Bos
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
Dynamics of signaling by PKA
SS Taylor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase
TC Tsou et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Loss of cholinergic pathways in vascular dementia of the Binswanger type
H Tomimoto et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension
J Deanfield et al.
JOURNAL OF HYPERTENSION (2005)
Emerging therapies for vascular dementia and vascular cognitive impairment
T Erkinjuntti et al.
STROKE (2004)
Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment
DH Endemann et al.
HYPERTENSION (2004)
AKAP signalling complexes: Focal points in space and time
W Wong et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Oxidative mechanism of arsenic toxicity and carcinogenesis
HL Shi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Role of endothelial dysfunction in atherosclerosis
J Davignon et al.
CIRCULATION (2004)
Weight reduction with very-low-caloric diet and endothelial function in overweight adults: Role of plasma glucose
M Raitakari et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus
JA Beckman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia - Endothelial assessment of risk from lipids in youth (EARLY) trial
MM Engler et al.
CIRCULATION (2003)
Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients
A Yildiz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure - Role of xanthine-oxidase and extracellular superoxide dismutase
U Landmesser et al.
CIRCULATION (2002)
Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy
KVH Sastry et al.
ANALYTICAL BIOCHEMISTRY (2002)
Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling
C Mehats et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Endothelial dysfunction in patients with coronary artery disease: A comparison of three frequently reported tests
SHJ Monnink et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2002)
Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension
A Virdis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
The fourth dimension in cellular signaling
JW Karpen et al.
SCIENCE (2001)
Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta
T Nakamura et al.
LIFE SCIENCES (2001)
Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism
HT Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats
HT Zhang et al.
PSYCHOPHARMACOLOGY (2000)